Galcanezumab recommended for migraine prevention in final NICE guidance
Clinical trial evidence shows it works better than best supportive care in both episodic and chronic migraine.
Published
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via
Are you a GP or Specialist Doctor, practising in UK, looking for:
- easy-to-digest, relevant updates and educational content
- a safe-space to share and collaborate with peers?
OnMedica is for you, sign up FOR FREE now!
No comments yet.